Late-Onset Inflammatory Bowel Disease-Like Syndrome after Ipilimumab Therapy: A Case Report

Case Reports in Oncology

Volumn 10, Issue 2, 2017, Pages 456-461

  Akel, Reem ^a   Anouti, Bilal ^a   Tfayli, Arafat ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Colitis; Immunotherapy; Inflammatory bowel disease; Ipilimumab; Melanoma; Side effects; Toxicity

Indexed keywords

IPILIMUMAB; MESALAZINE; PREDNISONE; STEROID; TEMOZOLOMIDE;

ABDOMINAL AORTIC ANEURYSM; ABDOMINAL CRAMP; ABDOMINAL PAIN; AGED; ARTICLE; BRAF GENE; CASE REPORT; CLINICAL ARTICLE; COLITIS; COLON BIOPSY; COLON ULCER; COLONOSCOPY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIARRHEA; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENTERITIS; GENE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY BOWEL DISEASE; LATE ONSET DISORDER; LUNG NODULE; MALE; METASTATIC MELANOMA; MULTIPLE CYCLE TREATMENT; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PRIORITY JOURNAL;

EID: 85020191312     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000475709     Document Type: Article

References (8)

1. Berman D, et al: Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma. Cancer Immun 2010;10:11.
2. Dubeau MF, et al: Drug-induced inflammatory bowel disease and IBD-like conditions. Inflamm Bowel Dis 2013;19:445-456.
3. Freeman HJ: Colitis associated with biological agents. World J Gastroenterol 2012;18:1871-1874.
4. Goethals L, et al: 18F-FDG PET/CT imaging of an anti-CTLA-4 antibody-Associated autoimmune pancolitis. Eur J Nucl Med Mol Imaging 2011;38:1390-1391.
5. Marthey L, et al: Cancer immunotherapy with anti-CTLA-4 monoclonal antibodies induces an inflammatory bowel disease. J Crohns Colitis 2016;10:395-401.
6. Mesonero F, et al: Ipilimumab-induced colitis: A new challenge for gastroenterologists (in Spanish). Gastroenterol Hepatol 2016;39:233-238.
7. Nancey S, et al: Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab is associated with a profound long-lasting depletion of Foxp3+ regulatory T cells: A mechanistic explanation for ipilimumab-induced severe enterocolitis? Inflamm Bowel Dis 2012;18:E1598-E1600.
8. Hussain SW, Pardi DS: Inflammatory bowel disease in the elderly. Drugs Aging 2010;27:617-624.